|
CMTM4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.361300E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.403900E-03 |
| Normal-vs-Stage2 |
3.006800E-01 |
| Normal-vs-Stage3 |
1.097970E-03 |
| Normal-vs-Stage4 |
1.80802999999452E-05 |
| Stage1-vs-Stage2 |
3.877600E-03 |
| Stage1-vs-Stage3 |
2.952800E-01 |
| Stage1-vs-Stage4 |
2.126300E-02 |
| Stage2-vs-Stage3 |
1.143010E-03 |
| Stage2-vs-Stage4 |
1.362460E-04 |
| Stage3-vs-Stage4 |
2.838000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.368800E-04 |
| Normal-vs-AfricanAmerican |
2.326800E-01 |
| Normal-vs-Asian |
1.846480E-04 |
| Caucasian-vs-AfricanAmerican |
3.349400E-01 |
| Caucasian-vs-Asian |
2.907800E-01 |
| AfricanAmerican-vs-Asian |
1.717210E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.417900E-02 |
| Normal-vs-Female |
3.936100E-03 |
| Male-vs-Female |
2.836600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.275300E-03 |
| Normal-vs-Age(41-60Yrs) |
4.597300E-03 |
| Normal-vs-Age(61-80Yrs) |
6.771800E-02 |
| Normal-vs-Age(81-100Yrs) |
3.359200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.517400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.759600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.421800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.647600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.966800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.859000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.480020E-02 |
| Classical-VS-Follicular |
1.65119999995245E-06 |
| Classical-VS-Other |
8.296000E-01 |
| Classical-VS-Normal |
3.985000E-04 |
| Tall-VS-Follicular |
2.37020000293242E-08 |
| Tall-VS-Other |
4.807000E-01 |
| Tall-VS-Normal |
4.41939999995533E-06 |
| Follicular-VS-Other |
2.359400E-01 |
| Follicular-VS-Normal |
2.090600E-01 |
| Other-VS-Normal |
5.542600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.832200E-02 |
| Normal-vs-N1 |
2.16050000001466E-07 |
| N0-vs-N1 |
1.98514999999455E-05 |
|
|
